concomitant disease

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
OBJECTIVE To evaluate ixekizumab, an anti-interleukin-17A (anti-IL-17A) monoclonal antibody, in 2 populations of rheumatoid… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2013
Highly Cited
2013
PURPOSE In patients with hormone-dependent postmenopausal breast cancer, standard adjuvant therapy involves 5 years of the… (More)
Is this relevant?
2013
2013
AIMS MicroRNAs (miRNAs) play an important role in the pathogenesis of structural alterations of the failing heart through their… (More)
Is this relevant?
2012
2012
OBJECTIVE To evaluate 4-year retention rates of tumor necrosis factor-α (TNF-α) inhibitors adalimumab, etanercept, and infliximab… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND Most knowledge on chronic fatigue (CF) and chronic fatigue syndrome (CFS) is based on clinical studies, not… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
OBJECTIVE Endoscopic therapy is increasingly being used in the treatment of high-grade intraepithelial neoplasia (HGIN) and… (More)
  • table 1
  • figure 2
  • figure 3
  • table 2
  • table 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Anti-IgE therapy could be particularly beneficial for patients with concomitant disease as it targets a common factor… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Review
2003
Review
2003
The treatment of onychomycosis has improved in recent years and many patients can now expect a complete and lasting cure. However… (More)
Is this relevant?
Review
2000
Review
2000
Over the past 20 years or so, the accuracy of using the conventional Riva-Rocci sphygmomanometer and Korotkoff ’s sounds to… (More)
  • table 1
  • table 3
Is this relevant?
1999
1999
BACKGROUND Treatment of gastroesophageal reflux disease (GERD) with modern acid-suppressive agents is supposed to be effective… (More)
Is this relevant?